SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-127495
Filing Date
2022-04-28
Accepted
2022-04-28 16:01:56
Documents
7
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d288567ddef14a.htm DEF 14A 883022
2 GRAPHIC g288567g04a26.jpg GRAPHIC 166370
3 GRAPHIC g288567g04a46.jpg GRAPHIC 99692
4 GRAPHIC g288567g18r02.jpg GRAPHIC 62398
5 GRAPHIC g288567g32p61.jpg GRAPHIC 25201
6 GRAPHIC g288567g33m33.jpg GRAPHIC 196761
7 GRAPHIC g288567g44m44.jpg GRAPHIC 146465
  Complete submission text file 0001193125-22-127495.txt   1825853
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36014 | Film No.: 22866353
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences